TASK DEFINITION: Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
PROBLEM: Paragraph: "There is no mention of cost. The story could have at least reported what the drug costs in its current use against blood cancer. The story did a good job of explaining both the potential benefits and harms of the drugs. This was a particular strength of this story and made it stand out in comparison with the LA Times blog story that we also reviewed. Harms were emphasized from the outset even in the headline in the AP story but were never mentioned in the LA Times story. And this story reminded readers of the side effects encountered with another MS drug, Tysabri. Outstanding job on this issue by the AP. The story did a very good job of explaining the studies. There is no sign of disease-mongering in this story. Two apparently independent sources were quoted. The story did a good job comparing the new drugs with existing approaches to treat MS. Story explains that the drug is already sold to treat a rare blood cancer and stated that ""it's too soon to know if the pills will be approved by the government or widely adopted by physicians."" It does not report, however, as the LA TImes blog did, that ""The drug company MD Serono, an affiliate of Merck, has requested approval from the Food and Drug Administration to market the tablet. However it recently received a ""refuse to file"" letter from the FDA, which means the agency is requiring additional information or data. MD Serono said it is pursuing the matter with the FDA and hopes to re-submit its application."" We think that's a crucial piece of information that affects availability, although, of course, doctors can still prescribe it for off-label use even before the FDA acts on the new request. The novelty of ""tests of the first two oral drugs developed for treating MS"" was clear in the story. It is clear that this story did not rely on a news release." Claim: MS pills show promise and risk, studies say

SOLUTION: Nice job explaining harms and benefits including putting the potential risks/harms right in the headline. The appeal of an oral drug for MS is clear. The risks emphasized in this story, though, raise important questions

PROBLEM: Paragraph: The 18,000-square-foot (1,700-square-meter) clinic in Fairview Heights, 12 miles (19 kilometers) east of St. Louis, will provide abortion services as well as family planning when it opens in mid-October, Planned Parenthood officials said at a news conference Wednesday. "While health care access in Missouri continues to hang on by a thread, Illinois is well-positioned to serve as a health care hub in the region," said Yamelsie Rodriguez, president and CEO of Planned Parenthood of the St. Louis Region and Southwest Missouri. Planned Parenthood has been battling Missouri's health department for months to try and keep open its St. Louis clinic. The state has refused to renew its license to perform abortions, citing concerns that include "failed abortions" that required additional surgeries. Missouri's Administrative Hearing Commission is deciding the fate of the St. Louis clinic. Meanwhile, Missouri women have been increasingly getting abortions at the Hope Clinic for Women in Granite City, Illinois, another St. Louis suburb. Deputy Director Alison Dreith said 58 percent of the abortions performed at the Hope Clinic through August of this year involved Missouri women, and 37 percent were women from Illinois. Missouri is among several conservative states to pass new restrictions on abortions in the hope that the increasingly conservative U.S. Supreme Court will eventually overturn Roe v. Wade. Republican Gov. Mike Parson signed legislation in May banning abortions at or beyond eight weeks of pregnancy, with exceptions for medical emergencies but not for rape or incest. A federal judge in August temporarily blocked implementation of the law until the legal challenge plays out in court, which could take several months. During an annual inspection of the St. Louis clinic in March, Missouri health investigators cited numerous concerns, including reports of failed abortions. Planned Parenthood said it has already addressed those concerns and defended its clinic. It claims the state is using the licensing process as an excuse to stop abortions. The state initially let the clinic's abortion license lapse at the end of May, then announced more definitively in June that it would not renew the license. The clinic remains open while the hearing commission decides its fate. Planned Parenthood officials say construction of the Fairview Heights clinic began last year, but details weren't released until near completion to avoid protesters and potential construction delays. Claim: New abortion clinic being built in Illinois, near St. Louis.

SOLUTION: Planned Parenthood has quietly been building a new abortion clinic in Illinois, just across the Mississippi River from St. Louis, as women concerned about the uncertain future of Missouri's sole abortion clinic flock across the state line.

PROBLEM: Paragraph: The Soil & Water Outcomes Fund, a partnership with the Iowa Soybean Association and third-party verification company Quantified Ventures, will then sell the environmental credits created to polluters such as cities and companies, including Cargill itself, Ryan Sirolli, Director of Row Crop Sustainability at Cargill, told Reuters. The program is a welcome source of farm revenue as the price of crops such as corn and soybeans hovers near the lowest in several years after the bruising trade war between the United States and China and, now, the coronavirus pandemic that has kneecapped the global economy. It also follows rising criticism of intensive farming practices and the companies that rely on them. Environmentalists criticized Cargill last year for delaying a self-stated goal of ridding its supply chain of crops produced on deforested land. Farmers in Iowa have enrolled almost 10,000 acres in a pilot program this spring, but the group is aiming to expand the program next season and broaden it beyond Iowa, Sirolli said. Farmer Lance Lillibridge of Vinton, Iowa, enrolled about 300 acres in the program this season and expects to get at least $35 an acre, which will offset some of his planting costs. "For a farmer, our margins are really small. In fact, right now there's no margin at all ... This is the first time that we are rewarded for our sustainability efforts," Lillibridge said. Funded by grants from Cargill and the Walton Family Foundation, the Soil & Water Outcomes Fund will pay farmers $30 to $45 per acre this season, depending on what environmental results are confirmed, said Adam Kiel, director of conservation for the Iowa Soybean Association. "We've got ambitions to go more broadly beyond Iowa in future years," Kiel said. "Farmers view this as another revenue source on their farm that's not a government payment." Cargill estimates the practices would prevent runoff of 100,000 pounds of nitrogen and 10,000 pounds of phosphorus this year and sequester 7,500 tons of carbon in soils, equivalent to taking 1,480 cars off the road. The fund is among the first of its kind to seek to verify and monetize the environmental benefits of farming practices such as no-till farming and planting cover crops like grass to prevent erosion. Historically, conservation schemes have paid farmers for more environmentally friendly practices but have not verified their benefits. "We're seeing a big shift in terms of the way we look at sustainability and how the industry is looking at it," Cargill's Sirolli said. Claim: Cargill-led fund to pay U.S. farmers for carbon capture, exchange credits.

SOLUTION:
Global commodities trader Cargill Inc [CARG.UL] starting this spring will pay American farmers for capturing carbon in their field soils and cutting fertilizer runoff, an executive said.